Bottom line
Is CLVRX a good fund? The bottom line
CLVRX is a share class of Calvert US Large-Cap Value Responsible Index Fund, an index large value mutual fund from Morgan Stanley.
It charges 0.19% — about $19 a year on every $10,000 invested, cheaper than 93% of large value funds we track.
It returned +16.7% over one year, +10.1% a year over five years, +10.7% a year over ten (as of Dec 31, 2025, per its prospectus).
With $2.1 billion in net assets and 527 holdings, its largest position is JPMorgan Chase & Co (4.5%) and the top 10 make up 17.6% of the portfolio.
What stands out
- Low cost: cheaper than 93% of large value peers
- Broadly diversified (527 holdings)
- No front-end sales load
Updated Nov 19, 2026
What CLVRX invests in
The Funds investment objective is to seek to track the performance of the Calvert US Large-Cap Value Responsible Index (the Index), which measures the investment return of large-capitalization stocks.
The Fund employs a passive management strategy designed to track, as closely as possible, the performance of the Index. The Fund invests in the common stock of each company in the Index in approximately the same proportion as represented in the Index itself. The Fund will normally invest at least 95% of its net assets, including borrowings for investment purposes, in securities contained in the Index (the 95% Policy). The Fund may also lend its securities. Calvert US Large-Cap Value Responsible Index. The Index is composed of the common stocks of large value companies that operate their businesses in a manner consistent with The Calvert Principles for Responsible Investment (the Calvert Principles). Large value companies are selected from the 1,000 largest publicly traded ?U.S. companies based on market capitalization and value style factors, excluding business development companies.…
From the fund's prospectus (filed Jan 27, 2026).
CLVRX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| CLVRX | +16.7% | +10.1% | +10.7% |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What CLVRX costs
On a $10,000 investment, CLVRX's 0.19% expense ratio costs about $19 a year. The prospectus estimates $358 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
CLVRX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | JPMorgan Chase & Co | 4.46% |
| 2 | Bank of America Corp | 2.22% |
| 3 | UnitedHealth Group Inc | 1.92% |
| 4 | Intel Corp | 1.50% |
| 5 | Wells Fargo & Co | 1.45% |
| 6 | Citigroup Inc | 1.38% |
| 7 | Procter & Gamble Co/The | 1.32% |
| 8 | Home Depot Inc/The | 1.23% |
| 9 | Goldman Sachs Group Inc/The | 1.11% |
| 10 | Verizon Communications Inc | 1.03% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 17.6% of the fund. See all top 25 holdings and asset mix →